ATE391917T1 - Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum - Google Patents

Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum

Info

Publication number
ATE391917T1
ATE391917T1 AT01112904T AT01112904T ATE391917T1 AT E391917 T1 ATE391917 T1 AT E391917T1 AT 01112904 T AT01112904 T AT 01112904T AT 01112904 T AT01112904 T AT 01112904T AT E391917 T1 ATE391917 T1 AT E391917T1
Authority
AT
Austria
Prior art keywords
blood
hemoglobin
monitoring
plasma
exogeneous
Prior art date
Application number
AT01112904T
Other languages
English (en)
Inventor
Michael J Malin
Phyllis Shapiro
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of ATE391917T1 publication Critical patent/ATE391917T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01112904T 2000-06-09 2001-06-05 Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum ATE391917T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21062500P 2000-06-09 2000-06-09

Publications (1)

Publication Number Publication Date
ATE391917T1 true ATE391917T1 (de) 2008-04-15

Family

ID=22783622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01112904T ATE391917T1 (de) 2000-06-09 2001-06-05 Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum

Country Status (6)

Country Link
US (1) US6623972B2 (de)
EP (1) EP1162461B8 (de)
JP (1) JP4694720B2 (de)
AT (1) ATE391917T1 (de)
DE (1) DE60133510T2 (de)
ES (1) ES2305014T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027347A1 (en) * 2001-05-25 2003-02-06 Phyllis Shapiro Automated method for correcting blood analysis parameter results affected by interference from exogenous blood substitutes in whole blood, plasma, and serum
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
JP2008534914A (ja) * 2005-01-17 2008-08-28 ユィロス・パテント・アクチボラグ 多目的流路
US7790464B2 (en) * 2006-05-04 2010-09-07 Blaze Medical Devices, LLC Blood hemolysis analyzer
US8906309B2 (en) 2009-04-27 2014-12-09 Abbott Laboratories Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
US8906308B2 (en) * 2010-01-15 2014-12-09 Abbott Laboratories Method for determining volume and hemoglobin content of individual red blood cells
US10853819B2 (en) 2011-04-14 2020-12-01 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US8514067B2 (en) 2011-08-16 2013-08-20 Elwha Llc Systematic distillation of status data relating to regimen compliance
CN103315710A (zh) * 2013-06-17 2013-09-25 无锡市第三人民医院 光电比色血液丢失计量笔及配套使用的引流瓶
EP2910926A1 (de) * 2014-02-19 2015-08-26 F.Hoffmann-La Roche Ag Verfahren und Vorrichtung zum Zuordnen einer Blutplasmaprobe
CA3022276C (en) 2016-05-11 2024-01-02 Nova Biomedical Corporation Whole blood so2 sensor
EP3655019A4 (de) 2017-07-18 2021-04-21 Virtech Bio, Inc. Hämoglobin enthaltende blutersatzstoffe und verfahren zu deren herstellung
GB2573126B (en) * 2018-04-24 2022-11-09 Entia Ltd A method and apparatus for determining haemoglobin concentration
WO2022032683A1 (zh) * 2020-08-14 2022-02-17 深圳迈瑞生物医疗电子股份有限公司 一种血液分析仪及血红蛋白检测方法
WO2022136327A1 (en) * 2020-12-22 2022-06-30 Radiometer Medical Aps Determining interference criticality based on analyte and cell-free hemoglobin concentrations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644462B1 (fr) * 1988-09-23 1993-07-09 Ire Celltarg Sa Nouveaux composes actifs sur les formes tissulaires de la malaria et procede de preparation
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
DE69330804T2 (de) * 1992-10-13 2002-07-18 Baxter International Inc., Deerfield Hemodialyseüberwachungssystem für Dialyseapparate
US5416026A (en) * 1993-10-04 1995-05-16 I-Stat Corporation Method for detecting the change in an analyte due to hemolysis in a fluid sample
CA2283154C (en) 1997-03-03 2009-03-24 Cme Telemetrix Inc. Method and apparatus for measurement of blood substitutes
US6114173A (en) * 1997-04-03 2000-09-05 Bayer Corporation Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
US5858794A (en) * 1997-05-13 1999-01-12 Bayer Corporation Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers

Also Published As

Publication number Publication date
DE60133510T2 (de) 2009-06-25
EP1162461A3 (de) 2002-03-06
JP4694720B2 (ja) 2011-06-08
DE60133510D1 (de) 2008-05-21
EP1162461B1 (de) 2008-04-09
ES2305014T3 (es) 2008-11-01
US6623972B2 (en) 2003-09-23
EP1162461B8 (de) 2008-06-18
US20020012904A1 (en) 2002-01-31
EP1162461A2 (de) 2001-12-12
JP2002040029A (ja) 2002-02-06

Similar Documents

Publication Publication Date Title
DE60133510D1 (de) Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum
Camenzind et al. Citrate storage affects thrombelastograph® analysis
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
WO2007062269A3 (en) Blood monitoring system
DK0985930T3 (da) Teststrimler til visuel bestemmelse af glucosekoncentrationen i blod
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
ATE203567T1 (de) Verbesserte in vitro verfahren, testkits und reagenzien zum screening von blutgerinnungsfehlern
DE60228755D1 (de) Verfahren und vorrichtung zur überwachung der analytkonzentration durch optischen nachweis
ATE346539T1 (de) Vorrichtung zur unblutigen bestimmung von blutwerten
ATE268477T1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
ATE546734T1 (de) Risikomarker für eine herzkreislaufkrankheit
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
ATE278186T1 (de) Elektrochemischer sensor zur bestimmung der blutgerinnung, ein entsprechendes blutgerinnungsmesssystem sowie ein verfahren zur bestimmung der blutgerinnung
ATE312550T1 (de) Vorrichtung zur segmentären bioimpedanzmessung von einem dialysepatienten
DE60312258D1 (de) Vorrichtung zur Abnahme von zu untersuchenden Blutproben z.B. zur Bestimmung des Glucosegehaltes
ATE406834T1 (de) System zur überwachung der konzentration von analyten in körperflüssigkeiten
DE69837709D1 (de) Vorrichtung und verfahren zur bestimmung des analytpegels
ATE181599T1 (de) Methode zur bestimmung von hämoglobinaddukten
DE59710488D1 (de) Vorrichtung und Verwendung einer Vorrichtung zur Bestimmung der Konzentration von Hämoglobinderivaten in einer unverdünnten, unhämolysierten Vollblutprobe
Kulinna et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life
WO2002097391A3 (en) Automated method of correcting for interference of mean cell hemoglobin concentration
BR9804648A (pt) Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos.
Hammond et al. The relationship of biological indices of lead exposure to the health status of workers in a secondary lead smelter
DE602005006633D1 (de) Reagenziensatz zum Nachweis von Lupus-Antikoagulant.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties